-
Symbol
-
RSLS on Nasdaq
-
Investment type
-
Equity / Common Stock, par value $0.001 per share
-
Latest Disclosed Shares Owned
-
200,000 shares
-
Security Ownership %
-
5.7%
Ayrton Capital LLC ownership in ReShape Lifesciences Inc. Common Stock, par value $0.001 per share (RSLS)
14 May 2025 - Ayrton Capital LLC has filed an SCHEDULE 13G form with the Securities and Exchange Commission (SEC) disclosing ownership of 200,000 shares of ReShape Lifesciences Inc. Common Stock, par value $0.001 per share (RSLS).
This represents 5.7% ownership of the company.
This is the first filing by Ayrton Capital LLC disclosing ownership of ReShape Lifesciences Inc. Common Stock, par value $0.001 per share (RSLS).